The irrational fixed dose combinations in the Indian drug market: an evaluation of prescribing pattern using WHO guidelines

Somesh P. Rayasam, Sujata S. Dudhgaonkar, Ganesh N. Dakhale, Rohan C. Hire, Prashant S. Deshmukh, Nilesh N. Gaikwad

Abstract


Background: Evaluation of the pattern of fixed dose combinations (FDCs) prescribing amongst the practitioners in a tertiary care hospital in Central India.

Methods: Nine hundred and ninety four prescriptions, containing 639 FDCs were scrutinized in the tertiary care hospital. After excluding the total and the interdepartmental repetitions, the numbers of FDCs were 278, which were considered for final analysis. Inclusion criteria were FDCs from the major out-patient department (OPD) of the tertiary care hospital from January 2011 to December 2011. FDCs from the wards, casualty, infectious disease unit, intensive cardiac care unit (ICCU), tuberculosis and chest and HIV unit were excluded from the study. FDCs were analysed for the different pattern of prescribing and rationalism. Results were expressed as percentages.

Results: Out of 639 FDCs, the most commonly prescribed FDCs were B complex (12.20%), pantoprazole plus domperidone (9.55%) and amoxicillin plus clavulanic acid (7.35%). Seventy percent of the FDCs were prescribed to the age group of 21-60 years. The FDCs were maximum from the department of medicine (25.59%), followed by surgery (15.47%) and ENT 13.69%. Out of 278 FDCs, only 5.4% were rational, and rest of the FDCs were irrational. Ninety five percent of all FDCs were brand names. The physicians were unaware of the active pharmacological ingredients (APIs) of 20.86% FDCs. Ninety two percent FDCs were available as over the counter (OTCs). Forty eight percent FDCs were costing from Rs. 0-50. There were 2.87% FDCs whose price was above Rs. 500.

Conclusions: Irrational FDCs are prescribed by all the departments. Physicians were ignorant about the essential drugs and FDCs. Patients didn’t have access to rational medicines. Therefore, physicians and regulators should be alerted in time. Regulatory actions or government laws should be made mandatory. Availability and access to 348 essential medicines for basic health care should be the priority of the government. Implementation of central drug standard control organisations (CDSCO) guidelines on industries for manufacture of FDCs must be made compulsory.


Keywords


Fixed dose combination, Irrational, OTC drugs, Prescription analysis, WHO guidelines

Full Text:

PDF

References


WHO drug information volume 17 [internet]. Geneva: WHO; 2003. Available at: http:// apps.who.int/medicinedocs/en/d/Js4955e/7.html.

Baiardini. I, Guerra. L, Pasquali, M, Bonadonna. P, Pasalaqua. G, Canonica. G.W. Quality of Life in Patients with Adverse Reactions to Drugs: Preliminary Results from A New Questionnaire. J Allergy Clin Immunol 2004;113(2):s70.

WHO technical report series. WHO expert committee on specifications for pharmaceutical preparations- thirty ninth report. Geneva: WHO; 2005.

Jain NK, Akarte A , Deshmukh PT , Kannojia P , Garud N , Yadav A. rationality of fixed dose combinations: An Indian scenario. The Pharma Research 2009; volume 01: 158-68.

Hindoliya M, Sharma PK, Dhaneria SP. Prescribing Trends of Fixed Dose Combinations in Teaching and Non Teaching Hospitals of Ujjain District. Journal of Pharmacy Research 2012; Volume 5(7): 3503-3505.

Tripathi KD. Essentials of medical Pharmacology. 6th edition. New Delhi; Jaypee brothers Medical Publishers (P) Ltd, 2008.

Hiller A, Silvanto M, Savolainen S, Tarkkila P. Propacetamol and diclofenac alone and in combination for analgesia after elective tonsillectomy. Acta Anaesthesiol Scand. 2004 Oct; volume 48(9): 1185-9.

Dhaneria SP. Rational and Irrational Drug Combinations. Drug Bulletin 2010 April; volume 35(2): 1-15.

Chambers HF, Deck DH. Beta-Lactam & other Cell Wall- & Membrane- Active Antibiotics. Basic and Clinical pharmacology by Bertram G. Katzung. 11thedition.New Delhi: Tata Mcgraw- Hill education private Ltd, 2009. Pg 773- 793.

Boushey HA. Drugs used in asthma. Basic and Clinical pharmacology by Bertram G. Katzung. 11th edition. . New Delhi: Tata Mcgraw- Hill education private Ltd, 2009. Pg 339- 356.

Robertson D, Maibach H. Dermatologic Pharmacology. Basic and Clinical pharmacology by Bertram G. Katzung. 11th edition. . New Delhi: Tata Mcgraw- Hill education private Ltd, 2009. Pg 1047-1065.

Deshmukh P, Purohit S. Rationality of Fixed Dose Combinations: Necessity to Weed out the Irrational Combinations Mushrooming in Pharmaceutical Industry. Pharmaceutical Reviews 2008; volume 6(1).

Government of India- Ministry of Health & Family Welfare (MOHFW). Notification G.S.R 218(E)[internet]. New Delhi: Government of India; 2011 March 16. Available at http://www.cipi.in/GSR218(E).pdf.

Government of India- Ministry of Health & Family Welfare (MOHFW). ). Notification G.S.R 82(E)[internet]. New Delhi: Government of India; 2011 February 10. Available at http:// www.cipi.in/Notification%20GSR% 2082(E).pdf.

CDSCO. Limitations of acetaminophen (paracetamol) in prescription combination products and giving box warning about its liver toxicity [internet]. New Delhi: CDSCO; 2011 September 23. Available at : http://www.cipi.in/DCGI%20CIR23092011.pdf.

Patel V, Vaidya R, Naik D, Borker P. Irrational drug use in India: a prescription survey from Goa. J Postgrad Med. 2005 Jan-Mar; volume 51(1): 9-12.

Goswami NN , Patel PP, Gandhi AM, Dikshit RK. An evaluation of knowledge, attitude and practice about fixed dose combinations in resident doctors. IJP. 2011; volume 43(7): 41-197.

WHO. Proposal of listing FDCs for infectous diseases [internet] WHO. Available at : http://archives.who.int/eml/expcom/children/Applications/ Monday_2_FDC.pdf.

Rathnakaru p et al. Prescribing patterns of fixed dose combinations in hypertension, diabetes mellitus and dyslipedimia among patients attending a cardiology clinic in a tertiary care teaching hospital in india. PharmacieGlobale (IJCP) 2011, volume 6 (05).

Chandler SC, Lekha S. Fixed dose drug combinations (FDCs): rational or irrational: a view point. Br J Clin Pharmacol. 2008 May; volume 65(5): 795–796.

Fixed dose combinations. Rational drugs- an update on rational drug use. January- June 2008; issue 31-32.

Chakraborti A. Fixed dose combinations in therapy [internet]: pharma voice; 2007 August. Available from http://www.expresspharmaonline .com/20070815/research02.shtml.

Gautam CS, Aditya S. Irrational drug combinations: Need to sensitize undergraduates. Indian J Pharmacol 2006;38:169-70.